1. BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A bispecific drug trial shows encouraging efficacy in non-small cell lung cancer patients.
2. U.S. forces disabled a non-compliant vessel in the Gulf of Oman to prevent a blockade violation, indicating potential geopolitical tension.
Biotech Efficacy, Gulf of Oman Tensions, Trader Insights
